Though Altman said he likely wouldn’t agree with Trump on “everything,” the OpenAI CEO said he believes “he will be ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
OpenAI CEO Sam Altman envisions a future where AI surpasses human intelligence, emphasizing that human skills will still hold ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
The White House broke its days-long silence about SpaceX CEO Elon Musk on Friday, as questions swirled about whether Musk had ...